Login erforderlich
Dieser Artikel ist Abonnenten mit Zugriffsrechten für diese Ausgabe frei zugänglich.
- Infos
Literaturtipps:
Heres, S. et al.: Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics. In: American Journal of Psychiatry 163(2), 2006, S. 185-194.
Perlis, R. H. et al.: Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry. In: American Journal of Psychiatry 162(10), 2005, S. 1957-1960.
Bhandari, M. et al.: Association between Industry Funding and Statistically Significant Pro-Industry Findings in Medical and Surgical Randomized Trials. In: Canadian Medical Association Journal 170(4), 2004, S. 477-480.
Heres, S. et al.: Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics. In: American Journal of Psychiatry 163(2), 2006, S. 185-194.
Perlis, R. H. et al.: Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry. In: American Journal of Psychiatry 162(10), 2005, S. 1957-1960.
Bhandari, M. et al.: Association between Industry Funding and Statistically Significant Pro-Industry Findings in Medical and Surgical Randomized Trials. In: Canadian Medical Association Journal 170(4), 2004, S. 477-480.
Schreiben Sie uns!
Beitrag schreiben